nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—Respiratory tract infection—Pravastatin—atherosclerosis	0.0154	0.0188	CcSEcCtD
Zanamivir—Lung disorder—Niacin—atherosclerosis	0.0139	0.0169	CcSEcCtD
Zanamivir—Nightmare—Rosuvastatin—atherosclerosis	0.0131	0.0159	CcSEcCtD
Zanamivir—Musculoskeletal pain—Lovastatin—atherosclerosis	0.0116	0.0141	CcSEcCtD
Zanamivir—Nightmare—Simvastatin—atherosclerosis	0.0104	0.0126	CcSEcCtD
Zanamivir—Musculoskeletal pain—Pravastatin—atherosclerosis	0.00982	0.012	CcSEcCtD
Zanamivir—Nightmare—Pravastatin—atherosclerosis	0.00937	0.0114	CcSEcCtD
Zanamivir—Influenza—Rosuvastatin—atherosclerosis	0.00849	0.0103	CcSEcCtD
Zanamivir—Bronchitis—Rosuvastatin—atherosclerosis	0.00817	0.00994	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.0075	0.00913	CcSEcCtD
Zanamivir—Influenza—Lovastatin—atherosclerosis	0.0072	0.00876	CcSEcCtD
Zanamivir—Sinusitis—Rosuvastatin—atherosclerosis	0.0071	0.00865	CcSEcCtD
Zanamivir—Influenza—Ezetimibe—atherosclerosis	0.00706	0.00859	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.00701	0.00854	CcSEcCtD
Zanamivir—Face oedema—Niacin—atherosclerosis	0.0069	0.0084	CcSEcCtD
Zanamivir—Bronchitis—Simvastatin—atherosclerosis	0.00647	0.00788	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.00636	0.00774	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.00634	0.00772	CcSEcCtD
Zanamivir—Influenza—Niacin—atherosclerosis	0.00618	0.00752	CcSEcCtD
Zanamivir—Influenza—Pravastatin—atherosclerosis	0.00609	0.00741	CcSEcCtD
Zanamivir—Arrhythmia—Rosuvastatin—atherosclerosis	0.00607	0.00739	CcSEcCtD
Zanamivir—Sinusitis—Lovastatin—atherosclerosis	0.00602	0.00733	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00595	0.00724	CcSEcCtD
Zanamivir—Bronchitis—Niacin—atherosclerosis	0.00595	0.00724	CcSEcCtD
Zanamivir—Sinusitis—Ezetimibe—atherosclerosis	0.00591	0.00719	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.00588	0.033	CbGpPWpGaD
Zanamivir—Sinusitis—Simvastatin—atherosclerosis	0.00563	0.00685	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.00553	0.031	CbGpPWpGaD
Zanamivir—Erythema multiforme—Lovastatin—atherosclerosis	0.00545	0.00663	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00538	0.00655	CcSEcCtD
Zanamivir—Erythema multiforme—Ezetimibe—atherosclerosis	0.00534	0.0065	CcSEcCtD
Zanamivir—Chills—Lovastatin—atherosclerosis	0.00517	0.00629	CcSEcCtD
Zanamivir—Cough—Rosuvastatin—atherosclerosis	0.00516	0.00629	CcSEcCtD
Zanamivir—Erythema multiforme—Simvastatin—atherosclerosis	0.0051	0.0062	CcSEcCtD
Zanamivir—Sinusitis—Pravastatin—atherosclerosis	0.00509	0.0062	CcSEcCtD
Zanamivir—Arthralgia—Rosuvastatin—atherosclerosis	0.00504	0.00613	CcSEcCtD
Zanamivir—Myalgia—Rosuvastatin—atherosclerosis	0.00504	0.00613	CcSEcCtD
Zanamivir—Haemoglobin—Niacin—atherosclerosis	0.00497	0.00605	CcSEcCtD
Zanamivir—Haemorrhage—Niacin—atherosclerosis	0.00495	0.00602	CcSEcCtD
Zanamivir—Confusional state—Rosuvastatin—atherosclerosis	0.00487	0.00593	CcSEcCtD
Zanamivir—Chills—Simvastatin—atherosclerosis	0.00484	0.00589	CcSEcCtD
Zanamivir—Infection—Rosuvastatin—atherosclerosis	0.0048	0.00584	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.0048	0.0269	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.0048	0.0269	CbGpPWpGaD
Zanamivir—Ill-defined disorder—Lovastatin—atherosclerosis	0.00465	0.00566	CcSEcCtD
Zanamivir—Erythema multiforme—Pravastatin—atherosclerosis	0.00461	0.00561	CcSEcCtD
Zanamivir—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00456	0.00556	CcSEcCtD
Zanamivir—Malaise—Lovastatin—atherosclerosis	0.00452	0.00551	CcSEcCtD
Zanamivir—Chills—Niacin—atherosclerosis	0.00444	0.0054	CcSEcCtD
Zanamivir—Malaise—Ezetimibe—atherosclerosis	0.00444	0.0054	CcSEcCtD
Zanamivir—Arrhythmia—Niacin—atherosclerosis	0.00442	0.00538	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.0044	0.00536	CcSEcCtD
Zanamivir—Chills—Pravastatin—atherosclerosis	0.00437	0.00532	CcSEcCtD
Zanamivir—Ill-defined disorder—Simvastatin—atherosclerosis	0.00435	0.0053	CcSEcCtD
Zanamivir—Arrhythmia—Pravastatin—atherosclerosis	0.00435	0.0053	CcSEcCtD
Zanamivir—Cough—Ezetimibe—atherosclerosis	0.00429	0.00522	CcSEcCtD
Zanamivir—Myalgia—Lovastatin—atherosclerosis	0.00427	0.0052	CcSEcCtD
Zanamivir—Arthralgia—Lovastatin—atherosclerosis	0.00427	0.0052	CcSEcCtD
Zanamivir—Anxiety—Lovastatin—atherosclerosis	0.00425	0.00518	CcSEcCtD
Zanamivir—Malaise—Simvastatin—atherosclerosis	0.00423	0.00515	CcSEcCtD
Zanamivir—Discomfort—Lovastatin—atherosclerosis	0.00422	0.00513	CcSEcCtD
Zanamivir—Myalgia—Ezetimibe—atherosclerosis	0.00419	0.0051	CcSEcCtD
Zanamivir—Arthralgia—Ezetimibe—atherosclerosis	0.00419	0.0051	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00416	0.00506	CcSEcCtD
Zanamivir—Discomfort—Ezetimibe—atherosclerosis	0.00414	0.00504	CcSEcCtD
Zanamivir—Pain—Rosuvastatin—atherosclerosis	0.00413	0.00503	CcSEcCtD
Zanamivir—Confusional state—Lovastatin—atherosclerosis	0.00413	0.00502	CcSEcCtD
Zanamivir—Anaphylactic shock—Lovastatin—atherosclerosis	0.00409	0.00498	CcSEcCtD
Zanamivir—Infection—Lovastatin—atherosclerosis	0.00407	0.00495	CcSEcCtD
Zanamivir—Confusional state—Ezetimibe—atherosclerosis	0.00405	0.00493	CcSEcCtD
Zanamivir—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00401	0.00489	CcSEcCtD
Zanamivir—Arthralgia—Simvastatin—atherosclerosis	0.00399	0.00486	CcSEcCtD
Zanamivir—Myalgia—Simvastatin—atherosclerosis	0.00399	0.00486	CcSEcCtD
Zanamivir—Infection—Ezetimibe—atherosclerosis	0.00399	0.00485	CcSEcCtD
Zanamivir—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00398	0.00484	CcSEcCtD
Zanamivir—Anxiety—Simvastatin—atherosclerosis	0.00398	0.00484	CcSEcCtD
Zanamivir—NEU2—Post-translational protein modification—F7—atherosclerosis	0.00396	0.0222	CbGpPWpGaD
Zanamivir—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00395	0.00481	CcSEcCtD
Zanamivir—Discomfort—Simvastatin—atherosclerosis	0.00395	0.0048	CcSEcCtD
Zanamivir—Ill-defined disorder—Pravastatin—atherosclerosis	0.00393	0.00479	CcSEcCtD
Zanamivir—Anorexia—Lovastatin—atherosclerosis	0.0039	0.00475	CcSEcCtD
Zanamivir—Skin disorder—Ezetimibe—atherosclerosis	0.0039	0.00475	CcSEcCtD
Zanamivir—Syncope—Niacin—atherosclerosis	0.00386	0.0047	CcSEcCtD
Zanamivir—Confusional state—Simvastatin—atherosclerosis	0.00386	0.0047	CcSEcCtD
Zanamivir—Urticaria—Rosuvastatin—atherosclerosis	0.00384	0.00467	CcSEcCtD
Zanamivir—Anaphylactic shock—Simvastatin—atherosclerosis	0.00383	0.00466	CcSEcCtD
Zanamivir—Malaise—Pravastatin—atherosclerosis	0.00382	0.00466	CcSEcCtD
Zanamivir—Abdominal pain—Rosuvastatin—atherosclerosis	0.00382	0.00465	CcSEcCtD
Zanamivir—Infection—Simvastatin—atherosclerosis	0.0038	0.00463	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.00379	0.0212	CbGpPWpGaD
Zanamivir—Loss of consciousness—Niacin—atherosclerosis	0.00379	0.00461	CcSEcCtD
Zanamivir—Cough—Niacin—atherosclerosis	0.00376	0.00458	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00373	0.00454	CcSEcCtD
Zanamivir—Cough—Pravastatin—atherosclerosis	0.0037	0.0045	CcSEcCtD
Zanamivir—Arthralgia—Niacin—atherosclerosis	0.00367	0.00446	CcSEcCtD
Zanamivir—Myalgia—Niacin—atherosclerosis	0.00367	0.00446	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00366	0.00445	CcSEcCtD
Zanamivir—Anorexia—Simvastatin—atherosclerosis	0.00365	0.00444	CcSEcCtD
Zanamivir—Dyspnoea—Lovastatin—atherosclerosis	0.00365	0.00444	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00364	0.00443	CcSEcCtD
Zanamivir—Arthralgia—Pravastatin—atherosclerosis	0.00361	0.00439	CcSEcCtD
Zanamivir—Myalgia—Pravastatin—atherosclerosis	0.00361	0.00439	CcSEcCtD
Zanamivir—Anxiety—Pravastatin—atherosclerosis	0.0036	0.00438	CcSEcCtD
Zanamivir—Dyspnoea—Ezetimibe—atherosclerosis	0.00358	0.00436	CcSEcCtD
Zanamivir—Discomfort—Pravastatin—atherosclerosis	0.00357	0.00434	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.00356	0.02	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.00356	0.02	CbGpPWpGaD
Zanamivir—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00356	0.00433	CcSEcCtD
Zanamivir—Decreased appetite—Lovastatin—atherosclerosis	0.00356	0.00433	CcSEcCtD
Zanamivir—Fatigue—Lovastatin—atherosclerosis	0.00353	0.0043	CcSEcCtD
Zanamivir—Anaphylactic shock—Niacin—atherosclerosis	0.00352	0.00428	CcSEcCtD
Zanamivir—Pain—Lovastatin—atherosclerosis	0.0035	0.00426	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.0035	0.0196	CbGpPWpGaD
Zanamivir—Confusional state—Pravastatin—atherosclerosis	0.00349	0.00425	CcSEcCtD
Zanamivir—Decreased appetite—Ezetimibe—atherosclerosis	0.00349	0.00425	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00349	0.00425	CcSEcCtD
Zanamivir—Asthenia—Rosuvastatin—atherosclerosis	0.00347	0.00422	CcSEcCtD
Zanamivir—Anaphylactic shock—Pravastatin—atherosclerosis	0.00346	0.00421	CcSEcCtD
Zanamivir—Fatigue—Ezetimibe—atherosclerosis	0.00346	0.00421	CcSEcCtD
Zanamivir—Shock—Niacin—atherosclerosis	0.00346	0.00421	CcSEcCtD
Zanamivir—Infection—Pravastatin—atherosclerosis	0.00344	0.00419	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.00344	0.0193	CbGpPWpGaD
Zanamivir—Pain—Ezetimibe—atherosclerosis	0.00343	0.00418	CcSEcCtD
Zanamivir—Skin disorder—Niacin—atherosclerosis	0.00341	0.00416	CcSEcCtD
Zanamivir—Dyspnoea—Simvastatin—atherosclerosis	0.00341	0.00415	CcSEcCtD
Zanamivir—Feeling abnormal—Lovastatin—atherosclerosis	0.00337	0.00411	CcSEcCtD
Zanamivir—Anorexia—Niacin—atherosclerosis	0.00335	0.00408	CcSEcCtD
Zanamivir—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00335	0.00407	CcSEcCtD
Zanamivir—Decreased appetite—Simvastatin—atherosclerosis	0.00333	0.00405	CcSEcCtD
Zanamivir—Feeling abnormal—Ezetimibe—atherosclerosis	0.00331	0.00403	CcSEcCtD
Zanamivir—Diarrhoea—Rosuvastatin—atherosclerosis	0.0033	0.00402	CcSEcCtD
Zanamivir—Fatigue—Simvastatin—atherosclerosis	0.0033	0.00402	CcSEcCtD
Zanamivir—Anorexia—Pravastatin—atherosclerosis	0.0033	0.00402	CcSEcCtD
Zanamivir—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00328	0.004	CcSEcCtD
Zanamivir—Pain—Simvastatin—atherosclerosis	0.00327	0.00399	CcSEcCtD
Zanamivir—Urticaria—Lovastatin—atherosclerosis	0.00325	0.00396	CcSEcCtD
Zanamivir—Abdominal pain—Lovastatin—atherosclerosis	0.00324	0.00394	CcSEcCtD
Zanamivir—Body temperature increased—Lovastatin—atherosclerosis	0.00324	0.00394	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Niacin—atherosclerosis	0.0032	0.0039	CcSEcCtD
Zanamivir—Dizziness—Rosuvastatin—atherosclerosis	0.00319	0.00389	CcSEcCtD
Zanamivir—Urticaria—Ezetimibe—atherosclerosis	0.00319	0.00388	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.00318	0.0178	CbGpPWpGaD
Zanamivir—Body temperature increased—Ezetimibe—atherosclerosis	0.00317	0.00386	CcSEcCtD
Zanamivir—Abdominal pain—Ezetimibe—atherosclerosis	0.00317	0.00386	CcSEcCtD
Zanamivir—Feeling abnormal—Simvastatin—atherosclerosis	0.00315	0.00384	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00315	0.00384	CcSEcCtD
Zanamivir—Dyspnoea—Niacin—atherosclerosis	0.00313	0.00381	CcSEcCtD
Zanamivir—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00313	0.00381	CcSEcCtD
Zanamivir—Dyspnoea—Pravastatin—atherosclerosis	0.00309	0.00376	CcSEcCtD
Zanamivir—NEU2—Post-translational protein modification—PLAUR—atherosclerosis	0.00307	0.0172	CbGpPWpGaD
Zanamivir—Decreased appetite—Niacin—atherosclerosis	0.00306	0.00372	CcSEcCtD
Zanamivir—Rash—Rosuvastatin—atherosclerosis	0.00305	0.00371	CcSEcCtD
Zanamivir—Dermatitis—Rosuvastatin—atherosclerosis	0.00304	0.0037	CcSEcCtD
Zanamivir—Urticaria—Simvastatin—atherosclerosis	0.00304	0.0037	CcSEcCtD
Zanamivir—Abdominal pain—Simvastatin—atherosclerosis	0.00303	0.00368	CcSEcCtD
Zanamivir—Body temperature increased—Simvastatin—atherosclerosis	0.00303	0.00368	CcSEcCtD
Zanamivir—Headache—Rosuvastatin—atherosclerosis	0.00303	0.00368	CcSEcCtD
Zanamivir—Hypersensitivity—Lovastatin—atherosclerosis	0.00302	0.00367	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.00301	0.0169	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.00301	0.0169	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.00301	0.0169	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.00301	0.0169	CbGpPWpGaD
Zanamivir—Decreased appetite—Pravastatin—atherosclerosis	0.00301	0.00366	CcSEcCtD
Zanamivir—Pain—Niacin—atherosclerosis	0.00301	0.00366	CcSEcCtD
Zanamivir—Fatigue—Pravastatin—atherosclerosis	0.00298	0.00363	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.00297	0.0167	CbGpPWpGaD
Zanamivir—Pain—Pravastatin—atherosclerosis	0.00296	0.0036	CcSEcCtD
Zanamivir—Hypersensitivity—Ezetimibe—atherosclerosis	0.00296	0.0036	CcSEcCtD
Zanamivir—Asthenia—Lovastatin—atherosclerosis	0.00294	0.00357	CcSEcCtD
Zanamivir—Asthenia—Ezetimibe—atherosclerosis	0.00288	0.00351	CcSEcCtD
Zanamivir—Gastrointestinal pain—Niacin—atherosclerosis	0.00287	0.0035	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.00287	0.0161	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—PLA2G7—atherosclerosis	0.00287	0.0161	CbGpPWpGaD
Zanamivir—Nausea—Rosuvastatin—atherosclerosis	0.00287	0.00349	CcSEcCtD
Zanamivir—Feeling abnormal—Pravastatin—atherosclerosis	0.00285	0.00347	CcSEcCtD
Zanamivir—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00283	0.00345	CcSEcCtD
Zanamivir—Hypersensitivity—Simvastatin—atherosclerosis	0.00282	0.00343	CcSEcCtD
Zanamivir—Diarrhoea—Lovastatin—atherosclerosis	0.0028	0.00341	CcSEcCtD
Zanamivir—Urticaria—Niacin—atherosclerosis	0.00279	0.0034	CcSEcCtD
Zanamivir—Abdominal pain—Niacin—atherosclerosis	0.00278	0.00338	CcSEcCtD
Zanamivir—Body temperature increased—Niacin—atherosclerosis	0.00278	0.00338	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.00275	0.0154	CbGpPWpGaD
Zanamivir—Urticaria—Pravastatin—atherosclerosis	0.00275	0.00335	CcSEcCtD
Zanamivir—Asthenia—Simvastatin—atherosclerosis	0.00275	0.00334	CcSEcCtD
Zanamivir—Diarrhoea—Ezetimibe—atherosclerosis	0.00275	0.00334	CcSEcCtD
Zanamivir—Abdominal pain—Pravastatin—atherosclerosis	0.00274	0.00333	CcSEcCtD
Zanamivir—Body temperature increased—Pravastatin—atherosclerosis	0.00274	0.00333	CcSEcCtD
Zanamivir—Dizziness—Lovastatin—atherosclerosis	0.00271	0.00329	CcSEcCtD
Zanamivir—Dizziness—Ezetimibe—atherosclerosis	0.00265	0.00323	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.00265	0.0149	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—LDLRAP1—atherosclerosis	0.00262	0.0147	CbGpPWpGaD
Zanamivir—Diarrhoea—Simvastatin—atherosclerosis	0.00262	0.00319	CcSEcCtD
Zanamivir—Vomiting—Lovastatin—atherosclerosis	0.0026	0.00317	CcSEcCtD
Zanamivir—Hypersensitivity—Niacin—atherosclerosis	0.00259	0.00315	CcSEcCtD
Zanamivir—Rash—Lovastatin—atherosclerosis	0.00258	0.00314	CcSEcCtD
Zanamivir—Dermatitis—Lovastatin—atherosclerosis	0.00258	0.00314	CcSEcCtD
Zanamivir—Headache—Lovastatin—atherosclerosis	0.00256	0.00312	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.00256	0.0143	CbGpPWpGaD
Zanamivir—Vomiting—Ezetimibe—atherosclerosis	0.00255	0.00311	CcSEcCtD
Zanamivir—Hypersensitivity—Pravastatin—atherosclerosis	0.00255	0.0031	CcSEcCtD
Zanamivir—Dizziness—Simvastatin—atherosclerosis	0.00253	0.00308	CcSEcCtD
Zanamivir—Rash—Ezetimibe—atherosclerosis	0.00253	0.00308	CcSEcCtD
Zanamivir—Dermatitis—Ezetimibe—atherosclerosis	0.00253	0.00308	CcSEcCtD
Zanamivir—Asthenia—Niacin—atherosclerosis	0.00252	0.00307	CcSEcCtD
Zanamivir—Headache—Ezetimibe—atherosclerosis	0.00251	0.00306	CcSEcCtD
Zanamivir—Asthenia—Pravastatin—atherosclerosis	0.00248	0.00302	CcSEcCtD
Zanamivir—NEU2—Metabolism—PLTP—atherosclerosis	0.00246	0.0138	CbGpPWpGaD
Zanamivir—Vomiting—Simvastatin—atherosclerosis	0.00243	0.00296	CcSEcCtD
Zanamivir—Nausea—Lovastatin—atherosclerosis	0.00243	0.00296	CcSEcCtD
Zanamivir—Rash—Simvastatin—atherosclerosis	0.00241	0.00294	CcSEcCtD
Zanamivir—Dermatitis—Simvastatin—atherosclerosis	0.00241	0.00294	CcSEcCtD
Zanamivir—Diarrhoea—Niacin—atherosclerosis	0.00241	0.00293	CcSEcCtD
Zanamivir—Headache—Simvastatin—atherosclerosis	0.0024	0.00292	CcSEcCtD
Zanamivir—Nausea—Ezetimibe—atherosclerosis	0.00238	0.0029	CcSEcCtD
Zanamivir—Diarrhoea—Pravastatin—atherosclerosis	0.00237	0.00288	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—HSPD1—atherosclerosis	0.00233	0.0131	CbGpPWpGaD
Zanamivir—Dizziness—Niacin—atherosclerosis	0.00232	0.00283	CcSEcCtD
Zanamivir—Dizziness—Pravastatin—atherosclerosis	0.00229	0.00279	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.00228	0.0128	CbGpPWpGaD
Zanamivir—Nausea—Simvastatin—atherosclerosis	0.00227	0.00277	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.00227	0.0127	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.00225	0.0126	CbGpPWpGaD
Zanamivir—Vomiting—Niacin—atherosclerosis	0.00224	0.00272	CcSEcCtD
Zanamivir—Rash—Niacin—atherosclerosis	0.00222	0.0027	CcSEcCtD
Zanamivir—Dermatitis—Niacin—atherosclerosis	0.00221	0.0027	CcSEcCtD
Zanamivir—Headache—Niacin—atherosclerosis	0.0022	0.00268	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.0022	0.0123	CbGpPWpGaD
Zanamivir—Vomiting—Pravastatin—atherosclerosis	0.0022	0.00268	CcSEcCtD
Zanamivir—Rash—Pravastatin—atherosclerosis	0.00218	0.00266	CcSEcCtD
Zanamivir—Dermatitis—Pravastatin—atherosclerosis	0.00218	0.00265	CcSEcCtD
Zanamivir—Headache—Pravastatin—atherosclerosis	0.00217	0.00264	CcSEcCtD
Zanamivir—NEU2—Metabolism—LTA4H—atherosclerosis	0.00214	0.012	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ABCG8—atherosclerosis	0.00214	0.012	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.00211	0.0118	CbGpPWpGaD
Zanamivir—Nausea—Niacin—atherosclerosis	0.00209	0.00254	CcSEcCtD
Zanamivir—Nausea—Pravastatin—atherosclerosis	0.00206	0.0025	CcSEcCtD
Zanamivir—NEU2—Post-translational protein modification—F2—atherosclerosis	0.002	0.0112	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.00199	0.0112	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—F7—atherosclerosis	0.00188	0.0105	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.00178	0.00995	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ABCG1—atherosclerosis	0.00169	0.00946	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—GHRL—atherosclerosis	0.00168	0.0094	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—ACE—atherosclerosis	0.00162	0.0091	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—FABP4—atherosclerosis	0.00159	0.00889	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—LCAT—atherosclerosis	0.00159	0.00889	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—APOA4—atherosclerosis	0.00156	0.00873	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CYP7A1—atherosclerosis	0.00153	0.00858	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—PLAUR—atherosclerosis	0.00146	0.00817	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.00146	0.00817	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—PLG—atherosclerosis	0.00143	0.00799	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CYP27A1—atherosclerosis	0.00141	0.00793	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.00139	0.0078	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.00136	0.00761	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ALOX15—atherosclerosis	0.00134	0.00752	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PLA2G2A—atherosclerosis	0.00134	0.00752	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—APOA2—atherosclerosis	0.00134	0.00752	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ALOX5AP—atherosclerosis	0.00134	0.00752	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ABCG5—atherosclerosis	0.00132	0.00742	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.00132	0.00742	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—IGF2—atherosclerosis	0.0013	0.00728	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—LPA—atherosclerosis	0.00128	0.00717	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—BGN—atherosclerosis	0.00124	0.00694	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.00123	0.00689	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—APOA5—atherosclerosis	0.00123	0.00687	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.00119	0.00668	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PLA2G1B—atherosclerosis	0.00118	0.00662	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.00117	0.00654	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.00116	0.00648	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.00115	0.00647	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ALOX5—atherosclerosis	0.00114	0.00639	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.00105	0.0059	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—MMP1—atherosclerosis	0.00104	0.00584	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—AGT—atherosclerosis	0.00103	0.00577	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—NAMPT—atherosclerosis	0.00102	0.00573	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.00102	0.0057	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—LIPC—atherosclerosis	0.00102	0.0057	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—APOC3—atherosclerosis	0.00101	0.00566	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—LEP—atherosclerosis	0.00101	0.00565	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—LDLR—atherosclerosis	0.001	0.00563	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CETP—atherosclerosis	0.000981	0.0055	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—F2—atherosclerosis	0.000951	0.00533	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—SCARB1—atherosclerosis	0.000939	0.00526	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000914	0.00512	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—HMGCR—atherosclerosis	0.000887	0.00497	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—INS—atherosclerosis	0.000862	0.00483	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—CCL2—atherosclerosis	0.000848	0.00475	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—IGF1—atherosclerosis	0.000834	0.00467	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—MMP2—atherosclerosis	0.000807	0.00452	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.0008	0.00448	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ABCA1—atherosclerosis	0.000791	0.00443	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—HMOX1—atherosclerosis	0.000678	0.0038	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—CXCL8—atherosclerosis	0.00067	0.00376	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—APOB—atherosclerosis	0.00065	0.00364	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GSTM1—atherosclerosis	0.000632	0.00354	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—LPL—atherosclerosis	0.00062	0.00348	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GPX1—atherosclerosis	0.000605	0.00339	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CD36—atherosclerosis	0.000589	0.0033	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—MTHFR—atherosclerosis	0.000559	0.00313	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PPARA—atherosclerosis	0.000548	0.00307	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—AGT—atherosclerosis	0.000531	0.00297	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—APOE—atherosclerosis	0.00052	0.00291	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CAV1—atherosclerosis	0.000515	0.00289	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—APOA1—atherosclerosis	0.000514	0.00288	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PIK3CG—atherosclerosis	0.000469	0.00263	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PPARG—atherosclerosis	0.000453	0.00254	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—INS—atherosclerosis	0.000444	0.00249	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ALB—atherosclerosis	0.000407	0.00228	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—NOS3—atherosclerosis	0.00039	0.00218	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PTGS2—atherosclerosis	0.000356	0.002	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—AKT1—atherosclerosis	0.000179	0.001	CbGpPWpGaD
